{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:29:28Z","timestamp":1793532568044,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62244-5","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T20:47:24Z","timestamp":1753735644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mitochondrial inflexibility ignites tumor immunogenicity in postoperative glioblastoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1415-6587","authenticated-orcid":false,"given":"Lulu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-290X","authenticated-orcid":false,"given":"Le","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myla","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9777-0674","authenticated-orcid":false,"given":"Zimei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0835-8803","authenticated-orcid":false,"given":"Kang-nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-7617","authenticated-orcid":false,"given":"Thomas","family":"Daubon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2357-1581","authenticated-orcid":false,"given":"Shilei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5641-3539","authenticated-orcid":false,"given":"Yanrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0031-1808","authenticated-orcid":false,"given":"Yulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"62244_CR1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0140-6736(18)31791-4","volume":"393","author":"U Herrlinger","year":"2019","unstructured":"Herrlinger, U. et al. Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG\/NOA-09): a randomised, open-label, phase 3 trial. Lancet 393, 678\u2013688 (2019).","journal-title":"Lancet"},{"key":"62244_CR2","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp, R. et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. Jama 318, 2306\u20132316 (2017).","journal-title":"Jama"},{"key":"62244_CR3","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","volume":"13","author":"A Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m, A. et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 13, 916\u2013926 (2012).","journal-title":"Lancet Oncol."},{"key":"62244_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","volume":"565","author":"N Hilf","year":"2019","unstructured":"Hilf, N. et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 565, 240\u2013245 (2019).","journal-title":"Nature"},{"key":"62244_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41582-018-0025-8","volume":"14","author":"ML Broekman","year":"2018","unstructured":"Broekman, M. L. et al. Multidimensional communication in the microenvirons of glioblastoma. Nat. Rev. Neurol. 14, 482\u2013495 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"62244_CR6","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.stem.2022.10.004","volume":"29","author":"SK Natarajan","year":"2022","unstructured":"Natarajan, S. K. & Venneti, S. Glioblastoma stem cell HISTArionics. Cell Stem Cell 29, 1509\u20131510 (2022).","journal-title":"Cell Stem Cell"},{"key":"62244_CR7","doi-asserted-by":"publisher","first-page":"eabn1128","DOI":"10.1126\/scitranslmed.abn1128","volume":"14","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy. Sci. Transl. Med. 14, eabn1128 (2022).","journal-title":"Sci. Transl. Med."},{"key":"62244_CR8","doi-asserted-by":"publisher","first-page":"eabq3558","DOI":"10.1126\/scitranslmed.abq3558","volume":"15","author":"F Yang","year":"2023","unstructured":"Yang, F. et al. Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy. Sci. Transl. Med. 15, eabq3558 (2023).","journal-title":"Sci. Transl. Med."},{"key":"62244_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.tcb.2023.03.009","volume":"33","author":"XX Zheng","year":"2023","unstructured":"Zheng, X. X. et al. Mitochondria in cancer stem cells: Achilles heel or hard armor. Trends Cell Biol. 33, 708\u2013727 (2023).","journal-title":"Trends Cell Biol."},{"key":"62244_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nature13611","volume":"514","author":"A Viale","year":"2014","unstructured":"Viale, A. et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514, 628\u2013632 (2014).","journal-title":"Nature"},{"key":"62244_CR11","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1126\/science.abq1053","volume":"381","author":"KC Mangalhara","year":"2023","unstructured":"Mangalhara, K. C. et al. Manipulating mitochondrial electron flow enhances tumor immunogenicity. Science 381, 1316\u20131323 (2023).","journal-title":"Science"},{"key":"62244_CR12","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1021\/acsnano.3c12434","volume":"18","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Blood\u2013brain barrier penetrating nanovehicles for interfering with mitochondrial electron flow in glioblastoma. ACS Nano 18, 9511\u20139524 (2024).","journal-title":"ACS Nano"},{"key":"62244_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41392-023-01487-4","volume":"8","author":"B He","year":"2023","unstructured":"He, B. et al. Cancer cell employs a microenvironmental neural signal trans-activating nucleus-mitochondria coordination to acquire stemness. Signal Transduct. Target. Ther. 8, 275 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"62244_CR14","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036\u20131046 (2018).","journal-title":"Nat. Med."},{"key":"62244_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.stem.2021.02.011","volume":"28","author":"RP Chakrabarty","year":"2021","unstructured":"Chakrabarty, R. P. & Chandel, N. S. Mitochondria as signaling organelles control mammalian stem cell fate. Cell Stem Cell 28, 394\u2013408 (2021).","journal-title":"Cell Stem Cell"},{"key":"62244_CR16","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.cell.2023.04.026","volume":"186","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway. Cell 186, 2361\u20132379.e2325 (2023).","journal-title":"Cell"},{"key":"62244_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen, M. F. et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374\u2013380 (2023).","journal-title":"Nature"},{"key":"62244_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","volume":"15","author":"M Lim","year":"2018","unstructured":"Lim, M., Xia, Y., Bettegowda, C. & Weller, M. Current state of immunotherapy for glioblastoma. Nat. Rev. Clin. Oncol. 15, 422\u2013442 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"62244_CR19","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","volume":"20","author":"CM Jackson","year":"2019","unstructured":"Jackson, C. M., Choi, J. & Lim, M. Mechanisms of immunotherapy resistance: lessons from glioblastoma. Nat. Immunol. 20, 1100\u20131109 (2019).","journal-title":"Nat. Immunol."},{"key":"62244_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer cell 13, 472\u2013482 (2008).","journal-title":"Cancer cell"},{"key":"62244_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41578-020-0209-x","volume":"5","author":"AK Gaharwar","year":"2020","unstructured":"Gaharwar, A. K., Singh, I. & Khademhosseini, A. Engineered biomaterials for in situ tissue regeneration. Nat. Rev. Mater. 5, 686\u2013705 (2020).","journal-title":"Nat. Rev. Mater."},{"key":"62244_CR22","doi-asserted-by":"publisher","first-page":"e2307759","DOI":"10.1002\/adma.202307759","volume":"36","author":"C Han","year":"2024","unstructured":"Han, C., Kundu, B. K., Liang, Y. & Sun, Y. Near-infrared light-driven photocatalysis with an emphasis on two-photon excitation: concepts, materials, and applications. Adv. Mater. 36, e2307759 (2024).","journal-title":"Adv. Mater."},{"key":"62244_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nchembio.2548","volume":"14","author":"C Feng","year":"2018","unstructured":"Feng, C. et al. Light-activated chemical probing of nucleobase solvent accessibility inside cells. Nat. Chem. Biol. 14, 276\u2013283 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"62244_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nchembio.1183","volume":"9","author":"D Kokel","year":"2013","unstructured":"Kokel, D. et al. Photochemical activation of TRPA1 channels in neurons and animals. Nat. Chem. Biol. 9, 257\u2013263 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"62244_CR25","doi-asserted-by":"publisher","first-page":"e202214875","DOI":"10.1002\/anie.202214875","volume":"62","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Highly twisted conformation thiopyrylium photosensitizers for in vivo near infrared-II imaging and rapid inactivation of coronavirus. Angew. Chem. 62, e202214875 (2023).","journal-title":"Angew. Chem."},{"key":"62244_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.trecan.2023.07.005","volume":"9","author":"NP Ward","year":"2023","unstructured":"Ward, N. P. Cys-regulation: oxidized CHK1 controls cross-compartment circuit of chemoresistance. Trends Cancer 9, 700\u2013702 (2023).","journal-title":"Trends Cancer"},{"key":"62244_CR27","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1093\/nar\/gkv790","volume":"43","author":"N Paquet","year":"2015","unstructured":"Paquet, N. et al. hSSB1 (NABP2\/ OBFC2B) is required for the repair of 8-oxo-guanine by the hOGG1-mediated base excision repair pathway. Nucleic Acids Res. 43, 8817\u20138829 (2015).","journal-title":"Nucleic Acids Res."},{"key":"62244_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7580","volume":"6","author":"K Tan","year":"2015","unstructured":"Tan, K. et al. Mitochondrial SSBP1 protects cells from proteotoxic stresses by potentiating stress-induced HSF1 transcriptional activity. Nat. Commun. 6, 6580 (2015).","journal-title":"Nat. Commun."},{"key":"62244_CR29","doi-asserted-by":"crossref","unstructured":"Graham A. J. et al. Transcriptional regulation of living materials via extracellular electron transfer. Nat. Chem. Biol. 20, 1329-1340 (2024).","DOI":"10.1038\/s41589-024-01628-y"},{"key":"62244_CR30","unstructured":"Zhang Y. et al. Implantable microneedle-mediated eradication of postoperative tumor foci mitigates glioblastoma relapse. n\/a, 2409857."},{"key":"62244_CR31","doi-asserted-by":"crossref","unstructured":"Jiao K. et al. Bioprinting extracellular vesicles as a \u201ccell-free\u201d regenerative medicine approach. Extracell. Vesicles Circ. Nucl. Acids. 4, 218-239 (2023).","DOI":"10.20517\/evcna.2023.19"},{"key":"62244_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48606-5","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse. Nat. Commun. 15, 4241 (2024).","journal-title":"Nat. Commun."},{"key":"62244_CR33","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro, A. & DeAngelis, L. M. Glioblastoma and other malignant gliomas: a clinical review. Jama 310, 1842\u20131850 (2013).","journal-title":"Jama"},{"key":"62244_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41568-022-00486-x","volume":"22","author":"RC Gimple","year":"2022","unstructured":"Gimple, R. C., Yang, K., Halbert, M. E., Agnihotri, S. & Rich, J. N. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat. Rev. Cancer 22, 497\u2013514 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"62244_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer cell 32, 42\u201356.e46 (2017).","journal-title":"Cancer cell"},{"key":"62244_CR36","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"62244_CR37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer, G., Galassi, C., Zitvogel, L. & Galluzzi, L. Immunogenic cell stress and death. Nat. Immunol. 23, 487\u2013500 (2022).","journal-title":"Nat. Immunol."},{"key":"62244_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","volume":"13","author":"M Jiang","year":"2020","unstructured":"Jiang, M. et al. cGAS-STING, an important pathway in cancer immunotherapy. J. Hematol. Oncol. 13, 81 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"62244_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-019-0721-x","volume":"12","author":"A Li","year":"2019","unstructured":"Li, A. et al. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy. J. Hematol. Oncol. 12, 35 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"62244_CR40","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.stem.2020.04.008","volume":"26","author":"P Vora","year":"2020","unstructured":"Vora, P. et al. The rational development of CD133-targeting immunotherapies for glioblastoma. Cell Stem Cell 26, 832\u2013844.e836 (2020).","journal-title":"Cell Stem Cell"},{"key":"62244_CR41","doi-asserted-by":"publisher","first-page":"43408","DOI":"10.1021\/acsami.0c12042","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase targeting siRNA from iron oxide nanoparticles. ACS Appl. Mater. Interfaces 12, 43408\u201343421 (2020).","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62244-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:42:16Z","timestamp":1757310136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62244-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62244"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62244-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6946"}}